Breakthrough Days: Collective Pandemic Intelligence

Confronting the crisis of COVID-19 has proven to be one of the world’s most critical challenges. One that is bigger than any singular government or organization. As possibly the greatest challenge of our generation, the response to COVID-19 requires collaboration and uncommon thinking, which is precisely why we’ve created the Collective Pandemic Intelligence Breakthrough Track as part of this year’s AI for Good Global Summit.

If harnessed for the good of humanity, AI and machine learning can help enable and accelerate existing efforts to solve our current crisis and pave the way for new solutions to this and future pandemics.

Speakers, Panelists and Moderators

    Chief Health Informatics Officer
    Dr. Andrew Muth is the Chief Health Informatics Officer for the VA Central Iowa Health Care System and also practices clinically as a hospitalist at Blank Children’s Hospital. Prior to his current roles, he completed his pediatric residency, as well as a two-year, accredited Clinical Informatics Fellowship in Phoenix, Arizona. Dr. Muth is board certified in Pediatrics through the American Board of Pediatrics (ABP) and in Clinical Informatics under the American Board of Preventive Medicine (ABPM). He earned both his Bachelor of Science in Emergency Medical Services and Doctor of Medicine from Creighton University in Omaha, Nebraska.
    Senior Director of Special Initiatives
    Jyothsna Buddharaju is the Senior Director of Special Initiatives for Boston University. She leads donor awareness and engagement for the University’s strategic priorities such as data sciences, infectious disease and sustainability among others. Prior to her tenure at Boston University, Jyothsna spent many years working for non-profits in the arts, STEM education and human services. Most recently, Jyothsna led corporate, foundation relations for the health sciences at UCLA. Jyothsna holds an MBA and BA in economics from the University of Michigan, Ann Arbor. She also graduated with Masters in Public Policy and Asian Studies from the University of Texas at Austin.
    VHA Senior Innovation Fellow
    VHA Innovation Ecosystem
    Amanda has been working as an Innovation Specialist at the Veterans Administration (VA) St Louis Health Care System within the Veterans Health Care Administration (VHA) Innovators Network part-time since October 2016, and full-time since April 2018. She loves to empower others, ignite curiosity, and wonder about what’s possible. Prior to her work in the Innovators Network, she held leadership roles in implementing programs for prevention, integrative and complementary care, and health behavior change at the VA. She has extensive experience and training in facilitation and advancing learning in adults. She has a PhD in Counseling Psychology from The Ohio State University.
    Partner and SVP
    Cody Simms is Partner and Senior Vice President at Techstars – the global platform for startup investment and innovation – and works as a steward of Techstars’ equity investments and venture capital funds for one of the most active early-stage venture investors in the world. Cody works at the board level with companies including WELL Health, Tasso, Two Bit Circus, StatMuse, Voatz and more. Earlier in his career, Cody held roles including Chief Product Officer at StumbleUpon, Vice President of Product Management at Yahoo, and Product Manager at The New York Times, Sprint, and NBC Internet / Cody holds an M.A. in Transnational Communication and Global Media from Goldsmiths College, University of London, and is a Phi Beta Kappa and Summa Cum Laude graduate of the University of Kansas with a B.A. in History and East Asian Languages and Cultures with emphasis on Mandarin Chinese.
    Senior Vice President, Research and Development, Professor of Practice
    Khalifa University of Science and Technology
    Dr. Steven Griffiths is Senior Vice President for Research and Development and Professor of Practice at the Khalifa University of Science and Technology. At Khalifa University, he oversees the development and implementation of the university’s research strategy and operations. Among his activities external to Khalifa University, Dr. Griffiths is advisor to the UAE Research Program for Rain Enhancement Science, a Zayed Sustainability Prize Selection Committee member, a member of the Dubai Future Council on Energy, an elected member of the Global Energy Prize International Award Committee and a member of the Global Governance of Artificial Intelligence Experts Working Group. He is also Associate Editor and Editorial Board member of Elsevier’s international journal Energy Strategy Reviews, Associate Editor and Editorial Board member of Springer’s international journal Energy Transitions and a non-resident Fellow of the Payne Institute at the Colorado School of Mines. His recent work includes examination of the convergence of machine intelligence and culture in low-carbon energy transitions. Dr. Griffiths holds a PhD in Chemical Engineering from MIT and an MBA from the MIT Sloan School of Management.
    Deputy CEO
    Life Sciences Queensland (LSQ)
    Dr Nagaraj Gopisetty is the Deputy CEO of Life Sciences Queensland and heads the business development program - Life Sciences Catalyst. The LS Catalyst program is a platform delivering targeted initiatives and services to support Queensland based Life Science Startups and entrepreneurs and facilitate the growth of Queensland's life sciences industry. Nagaraj is an innovation architect with a proven track record in technology translation and commercialisation. Prior to joining LSQ, Nagaraj was the Business Development and Innovation Education Manager at the Translational Research Institute. He also worked as a technology transfer professional within Australian Universities and medical research institutes along with short working stints within government, a biotechnology start-up and leading multi-national pharmaceutical companies. He is experienced in business development, research translation and commercialisation, intellectual property management, contract and licence negotiations, projects management. He is also experienced in facilitating alliance management and stakeholder engagement involving partnerships with academia, clinicians, industry and other stakeholders. Nagaraj holds a Bachelor of Pharmacy degree from India, a Masters in Biotechnology (Hon’s) from Griffith University and a PhD in Pharmacy from the University of Queensland. He also has an MBA from the University of Newcastle. He is an active mentor on the IMNIS program, grant reviewer on government and private funding schemes and represents on a number of key working groups and steering committees Nagaraj is passionately interested in education and training programs aimed at improving current practices and processes within the knowledge exchange, knowledge transfer and entrepreneurship in the life sciences sector.
    Director; Chief Medical Informatics Officer (CMIO) VA Palo Alto
    VA National Center for Collaborative Healthcare Innovation (NCCHI)
    Dr. Thomas Osborne is the Director for the National Center for Collaborative Healthcare Innovation (NCCHI) and is also the Chief Medical Informatics Officer (CMIO) at VA Palo Alto Healthcare System. He is currently leading multidisciplinary teams in the co-development of pioneering healthcare solutions throughout VA, with other government agencies, and with leading technology companies. His work has been published in numerous medical journals and textbooks with a focus on related topics such as artificial intelligence, sensor technology, and the future of healthcare. Dr. Osborne received his medical degree from Dartmouth Medical School, completed his residency at Harvard Mount Auburn Hospital, and fellowship at Harvard Massachusetts General Hospital. He is board certified in both Diagnostic Radiology and Neuroradiology. Dr. Osborne is a staff neuroradiologist at VA Palo Alto Healthcare System and Clinical Assistant Professor (affiliated) at Stanford University School of Medicine.
    VP of Partnerships and Strategic Engagements
    XPRIZE Foundation
    Andrew Tauhert is VP of Partnerships and Strategic Engagements at XPRIZE. He and his team focus on establishing strategic relationships and ecosystems to advance the goals of both XPRIZE and its partners - aligning XPRIZE among a system of entities globally such that each partner contributes to and benefit from XPRIZE’s prizes, initiatives and platforms. Andrew also maintains a leadership position in the XPRIZE Pandemic Alliance COVID-19 responsive initiative as well as the XPRIZE Data Collaborative – working with technology, data and other ecosystem partners to use data sciences, machine learning and AI to solve challenges. Prior to XPRIZE, Andrew has had an extensive career driving successful results in large enterprises and startups operating throughout high tech, telecom/networking, data and AI. Andrew is the former COO of Prodea Systems a leader in Internet of Things Solutions as well as Founder and Managing Director of VaticX Inc., a global accelerator with best practices to optimize value creation for growth stage AI, DLT, IoT, and Edge Computing companies.
    Senior Vice President & Global Industry Solutions Lead, Techstars
    Alex Tepper is a Managing Director in GE’s Ventures group, where he focuses on growth strategy and venture investments in Robotics and other disruptive technologies. Prior to that role, Alex was GE’s Global Director of Innovation where he worked across all the GE businesses and the Global Research Center to design and bring to market breakthrough products and new business models. He is also the co-founder of the GE Open Innovation (crowd-sourcing) Center of Excellence. Prior to GE, Alex was at American Express where he led a marketing group, new product development and then the Strategy and Innovation group for the consumer division. Between GE and AMEX, he spent a year at a non-profit, advising entrepreneurs in the developing world.
    Director, Techstar Investments, Techstars
    Kevin Liu is a director at Techstars Investments, where he works with companies across Techstars' portfolio on deal evaluation, fundraising, and value creation initiatives. Prior to joining Techstars, Kevin led Data Science & Analytics at Mattermark (sold to FullContact), a data analytics company focused on structuring business information. Kevin is an early investor in Culture Biosciences, Retool, Seldon, and Bottomless. Kevin specialises in product management, data strategy, and B2B software companies and mentors at Google Launchpad and First Round Capital.
    Co-founder & Co-CEO of Poppy
    Elizabeth Caley is co-founder & co-CEO of Poppy, the world’s first pathogen monitoring and protection network. Based in San Francisco, Ms. Caley has been building and leading fast-growing global technology companies over the last 20 years. Prior to starting Poppy, Ms. Caley was the Chief Operating Officer of Meta, an artificial intelligence company focused on accelerating scientific progress. In 2017, Meta was acquired by the Chan Zuckerberg Initiative, Mark Zuckerberg and Priscilla Chan’s tech philanthropy. Prior to Meta, she held executive roles at global software companies such as Microsoft, Hummingbird (OpenText), and Firmex. Honored as one of the most inspiring women in STEM and as one of the most inspiring women in Canada, Ms. Caley is an active contributor to the Bay Area, Oxford, & Canadian technology communities as a mentor, advisor, angel investor, and speaker. Ms. Caley holds MBAs from the University of Toronto & University of St. Gallen, Switzerland, with multiple awards for leadership and academic achievement.
    CEO & Founder, Deep 6 AI
    Deep 6 AI
    Wout Brusselaers is the CEO and founder of Deep 6 AI. Wout started his career as a diplomat in the Middle East before joining global management consulting firm, McKinsey & Company, serving a wide variety of industries across Asia. Next, Wout founded an extreme sports adventure company in Singapore. He then spent five years in the high-stakes world of international security, growing and leading a 22,000-headcount organization across four continents into a $500M global player. Wout co-founded Deep 6 AI as a cutting-edge AI platform for the Intelligence Community, arguably the most complex data environment in the world. Since 2016, Deep 6 AI has focused exclusively on healthcare, working with industry leaders such as Cedars-Sinai Medical Center. Deep 6 AI now uses its AI expertise to accelerate patient recruitment and get life-saving treatments to people faster. Wout is a frequent speaker on artificial intelligence in healthcare and works closely with hospitals, pharma companies, and research institutes on patient recruitment programs.
    Computer Scientist, Argonne National Laboratory
    Argonne National Laboratory
    Ravi is a computer scientist in the Data Science and Learning division at Argonne National Laboratory and is Senior Scientist at the Center of Research Computing at the University of Chicago. He is an innovation fellow at the Polsky Center of Entrepreneurship at University of Chicago. Ravi led several successful large projects in NSF, NIH and DoE. His research interests are in building sustainable, scalable services for science, reproducible research, large-scale data management and analysis. He is one of three key contributors to the National Institutes of Health $100M Cancer Biomedical Informatics Grid (caBIG), which linked 60 NIH-funded cancer centers and clinical sites engaged in cancer research. For his efforts in project management, tool development, and collaboration, Ravi received several Outstanding Achievement Awards from NIH. Ravi led the design and implementation of scientific and high-performance workflows under the caGrid toolkit. Ravi leads the Globus Genomics project (, which is used by thousands of researchers across the world for genomics, proteomics, and other biomedical computations on Amazon cloud and other platforms. He architected the Globus Galaxies platform that underpins Globus Genomics and several other cloud-based gateways realizing the vision of Science as a Service for creating, maintaining sustainable services for science. Ravi plays an important role in applying large-scale data analysis, deep learning to problems in biology. For his work on “Cancer Moonshot” project, he received the Department of Energy Secretary award in 2017.
    Professor of Public Policy & Director of Research, Schar School of Policy and Government, George Mason University
    George Mason University
    Dr. Naoru Koizumi is Professor of Public Policy and the Director of Research in the Schar School of Policy and Government at George Mason University. She specializes in medical policies, particularly in the fields of organ transplantation and the end-stage kidney and liver diseases. Her research focuses on the applications of various quantitative methods such as biostatistics, Geographic Information Systems (GIS), simulation and mathematical optimization to analyze various clinical and policy questions related to organ transplantation and other chronic disease treatments. Her projects funded by NIH and NSF include simulations and optimizations of organ allocation (NIH-R21) and bed allocation in a mental health system (NIH-R21 & R01), simulation of slum expansion in India (NSF) and mathematical analysis of illicit kidney trade networks (NSF). Her grant from the Bill & Melinda Gates Foundation investigated effectiveness of ICT-based interventions designed to enhance medication adherence among Tuberculosis patients in India.
    Executive Director, Office of Health Equity, US Veterans Health Administration
    Office of Health Equity
    Ernest Moy, MD, MPH, is the executive director of the Office of Health Equity in the US Veterans Health Administration. The office supports and coordinates efforts to understand and reduce disparities in health and health care affecting veterans. Prior to joining VHA, he was a medical officer in the Office of Analysis and Epidemiology at the National Center for Health Statistics of the US Centers for Disease Control and Prevention. Previously he was director of the division in the Center for Quality Improvement and Patient Safety at the Agency for Healthcare Research and Quality (AHRQ), which designed and produced the National Healthcare Quality and Disparities Report and related web tools. The report is submitted annually to Congress.
    Professor at the Dept. of Electrical & Computer Engineering: Khalifa University; Aristotle Univ. of Thessaloniki
    Khalifa University of Science and Technology
    Leontios J. Hadjileontiadis (IEEE S’87–M’98–SM’11) was born in Kastoria (π-1966), Greece. He received the Diploma Degree in Electrical Engineering in 1989 and the Ph.D. Degree in Electrical and Computer Engineering in 1997, both from the Aristotle University of Thessaloniki (AUTH), Thessaloniki, Greece. He also received a Diploma Degree in Musicology, AUTH, in 2011, and the Ph.D. Degree in Music Composition from the University of York, York, U.K., in 2004. His research interests include advanced signal processing, machine learning, biomedical engineering, affective computing and active and healthy ageing. His publication record includes 298 publications [6 Books, 2Book Editing, 24 Book Chapters, 112 Journal papers, 154 papers in Conference Proceedings]; h=40; No citations: 6132 []. He has vast experience in project management, coordinating so far European and UAE projects of more than $10 million. Prof. Hadjileontiadis has been awarded, amongst other awards, as innovative researcher and champion faculty from Microsoft, USA (2012), the “Silver Award in Teaching Delivery” at the Reimagine Education Awards (2017-2018), the “Healthcare Research Award” by the Dubai Healthcare City Authority Excellence Awards (2019), and as the coordinator, the “Award of the most innovative project 2020” for the H2020 project “i-PROGNOSIS”, AgeingFit (2020, Nice, France). He is a Senior Member of IEEE.
    Senior Director of the Artificial Intelligence and Intelligent Systems Institute, Khalifa University
    Khalifa University of Science and Technology
    Ernesto Damiani (Senior Member, IEEE) is the Senior Director of the Artificial Intelligence and Intelligent Systems Institute, Khalifa University, a Leader of the big data area at Etisalat British Telecom Innovation Center, the President of the Consortium of Italian Computer Science Universities (CINI), and Full Professor with Universita’ degli Studi di Milano, where he leads the SESAR Lab. His work has more than 17 000 citations on Google Scholar and more than 6 700 citations on Scopus, with an H-index of 35. His areas of interest include artificial intelligence, machine learning, big data analytics, edge/cloud security and performance, and cyber-physical systems. He was a recipient of the Stephen Yau Award from the Service Society, the Outstanding contributions Award from IFIP TC2, the Chester-Sall Award from IEEE IES, and a doctorate honoris causa from INSA Lyon, France, for his contribution to big data teaching and research.
    Global Chief Medical Officer (CMO) and VP of Healthcare for Microsoft
    Dr. David C. Rhew is the Global Chief Medical Officer (CMO) and Vice-President (VP) of Healthcare for Microsoft. He is the Chairman of the Health and Fitness Technology Division for the Consumer Technology Association and serves on CTA’s Board of Industry Leaders. He co-holds six U.S. technology patents that enable authoring, mapping, and integration of clinical decision support into the electronic health record. David is currently an Adjunct Professor at the Stanford University School of Medicine. Dr. Rhew received his Bachelors of Science degrees in computer science and cellular molecular biology from the University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai and infectious diseases at the University of California, Los Angeles. He has served as CMO and VP for Samsung; Senior Vice-President and CMO at Zynx Health Incorporated; clinician/researcher in the Division of Infectious Diseases at the VA Greater Los Angeles Healthcare System; and Associate Clinical Professor of Medicine at UCLA. Dr. Rhew has served on the National Quality Forum’s (NQF) Executive Committee for Consensus Standards and Approval.
    Global Head of Medical AI at NVIDIA
    Mona is the Global Head of Medical AI at NVIDIA. She brings a unique perspective with her varied experience in clinical medicine, medical applications, and business. She is a board certified cardiac surgeon and the previous Chief Medical Officer of a digital health company. She holds an MBA in Management Information Systems, and has worked on Wall Street. Her ultimate goal is the betterment of medicine through AI.
    Managing Director of Techstars
    Since graduation, tech startups have given me amazing ups and dreadful downs in a wide array of roles and industries. Among them was starting Context.IO, an API that makes it easy and fast for developers to integrate email data in their applications. It was acquired by Return Path in 2012 where the product lived on for many years. My background is engineering but I love bringing tech products to market and selling them as much as I love building them.
    Founder and Chairman at HitchinRock Advisors
    HitchinRock Advisors
    Viren Mahurkar is Founder and Chairman of HitchinRock Advisors, a boutique consulting firm for financial investors and mid-sized companies that need specialized expertise in M&A, licensing or investments in biomedical assets and technologies. He brings global experience and divides his time between London, New York, Singapore. Over the last 30 years, Viren has held global and regional leadership roles at pharmaceutical and medtech companies including Pfizer, Novartis, and Wockhardt. He has led projects and deals involving US, European and Asian pharma, biotechs and medtechs, across the range from new technologies and unmet medical needs to ongoing commercial operations. He enjoys collaborating closely with R&D, clinical, regulatory, manufacturing, IP, legal, product launch, market access, sales & marketing colleagues. Viren also has years of senior banking experience with Citibank, Standard Chartered, Ambit Capital and ICICI Securities. He has worked across trade finance, FX advisory, merchant banking and securities services and retains close ties to US, Europe and Asia investor ecosystems. Viren is deeply interested in the intersection of biomedical innovation and its financing. He is a speaker and active participant on these and related topics at pharma, biotech, medtech, BD&L and investor forums. His qualifications include an MBA (University of Delhi); MSc (London School of Economics); an executive leadership programme (Harvard Business School); Alternative investment (CAIA); Quant Finance (CQF) and advanced courses in biotech and healthcare.
    CTO at WELL Health
    WELL Health
    Thor Clark is the Chief Technology Officer at WELL Health, the leading enterprise SaaS healthcare company delivering patient engagement and communication solutions for large healthcare systems, including Cedars-Sinai, MemorialCare, Houston Methodist, UNC, and others. WELL manages patient communication for tens of millions of patients. Thor has built enterprise SaaS solutions at scale in a number of highly regulated industries over the past 20 years, including healthcare, transaction management, and financial services. He has a B.A. Cognitive Science with an emphasis in machine learning and computer science from University of California Berkeley, and an MBA from University of California Irvine.

Hourly Schedule

Tuesday 22 September

19:30 - 21:00
Day 1: Project presentations

Wednesday 23 September

19:30 - 21:00
Day 2: Prize-design workshop

Thursday 24 September

19:30 - 21:00
Day 3: Gathering resources/support
VP of Partnerships and Strategic Engagements
Confronting the crisis of COVID-19 has proven to be one of the world’s most critical challenges. One that is bigger than any singular government or organization. As possibly the greatest challenge of our generation, the response to COVID-19 requires collaboration and uncommon thinking, which is precisely why we’ve created the Collective Pandemic Intelligence Breakthrough Track as part of this year’s AI for Good Global Summit. If harnessed for the good of humanity, AI and machine learning can help enable and accelerate existing efforts to solve our current crisis and pave the way for new solutions to this and future pandemics.


22 Sep 2020 - 24 Sep 2020


CEST, Geneva
19:30 - 21:00



Join the conversation